The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a commentary detailing what is being described as a Crisis in Clinical Research. The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with...
This webinar on July 10th examined how cell therapies are being utilized around the globe and in resource limited settings. It featured physicians from India, Mexico, and Egypt to discuss their experience in evaluating cell therapies as a treatment option as well as how they overcame challenges...
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a comprehensive summary on the Surrogate Endpoints Virtual Summit , which was held on April 5, 2024. Surrogate endpoints have been instrumental for the advancement of immunotherapy, including dozens of...
Digital pathology is becoming an increasingly important technique for immunotherapy drug development and clinical care. As AI becomes further entrenched across the field of immunotherapy, researchers have begun considering how AI and digital pathology may coexist for enhanced pathologic analyses...
This webinar on June 5th reviewed effective strategies for cancer immunotherapy administration by providing a glance at IO access across the United States, the United Kingdom, and Nigeria. It featured presentations on different models of access, the challenges related to increasing access to...
AI is being investigated for real-time monitoring of patients receiving immunotherapy for immune-related adverse events (irAE). Earlier and more accurate detection of toxicities can vastly improve patient outcomes. The first webinar in our series on May 2nd educated participants on the current...
SITC thanks Policy Committee chair Dr. Ryan Sullivan and many other SITC members for assisting with this year's hill visits. SITC members held over 25 Congressional meetings, including in-person meetings with Dr. Sullivan, on a host of important issues affecting cancer immunotherapy research. ...
The Global Access and Impact Committee, in collaboration with the Diversity, Equity, and Inclusion Committee, is pleased to launch SITC's first educational program crafted specifically for international audiences, titled " Increasing Access to IO: A Global Webinar Series ". This series will...
SITC has provided full comments on a recently released FDA Draft Guidance: "Potency Assurance for Cellular and Gene Therapy Products". Please find the letter in its entirety HERE . #Policy
SITC has provided meeting coverage of the March 15th ODAC meeting. The coverage includes an overview of the discussion, including representation of the different stakeholder perspectives on each issue, as well as a summary of all recommendations from ODAC. The coverage can be found in its...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us